These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5014448)

  • 1. Teratogenic action of heterologous kidney antisera in mice.
    McCallion DJ
    Teratology; 1972 Feb; 5(1):11-7. PubMed ID: 5014448
    [No Abstract]   [Full Text] [Related]  

  • 2. The production of congenital malformations using tissue antisera. X. Effectiveness of kidney antigens treated with neuraminidase or trypsin.
    Leung CC; Brent RL
    Pediatr Res; 1972 Nov; 6(11):822-31. PubMed ID: 4118843
    [No Abstract]   [Full Text] [Related]  

  • 3. The embryolethality and localization of antikidney serum in the pregnant mouse, Mus musculus.
    Gebhardt DO; Baart de la Faille-Kuyp ; Nagel J
    Teratology; 1970 May; 3(2):143-51. PubMed ID: 4192437
    [No Abstract]   [Full Text] [Related]  

  • 4. [Some mechanisms of immunopathological damage].
    Zubzhitskiĭ IuN
    Vestn Akad Med Nauk SSSR; 1971; 26(3):88-91. PubMed ID: 4931991
    [No Abstract]   [Full Text] [Related]  

  • 5. The production of congenital malformations using tissue antisera. VII. Yolk-sac antiserum.
    Brent RL; Johnson AJ; Jensen M
    Teratology; 1971 Aug; 4(3):255-75. PubMed ID: 5105932
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunofluorescence microscopy studies of placenta, vitelline sac and maternal organs of rats following injections of rabbit-anti-rat placental serum at various sites].
    Oswald B; Schlag B; Franke H; Malberg K; Goetze E
    Acta Biol Med Ger; 1971; 27(3):627-38. PubMed ID: 4947965
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-kidney serum and embryonal development of the rat].
    Giavini E; Amirante GA; Colombo R; Leone VG
    Acta Embryol Exp (Palermo); 1973; 2():145-54. PubMed ID: 4754123
    [No Abstract]   [Full Text] [Related]  

  • 8. [[Teratogenic effects of treatment with antibodies common to the kidney and placenta, in rats]omuni a rene e placenta].
    Amirante G; Colombo R; Giavini E; Leone VG
    Acta Embryol Exp (Palermo); 1975; (3):163-9. PubMed ID: 1232723
    [No Abstract]   [Full Text] [Related]  

  • 9. The production of congenital malformations using tissue antisera. XI. Antisera to acellular visceral yolk sac.
    Leung CC; Brent RL; Koszalka TR
    Teratology; 1972 Dec; 6(3):317-30. PubMed ID: 4345336
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunologic and immunomorphologic study of experimental amyloidosis in mice].
    Zybzhitskiĭ IuN
    Arkh Patol; 1967; 29(5):43-9. PubMed ID: 4882261
    [No Abstract]   [Full Text] [Related]  

  • 11. Maternal-fetal incompatibility. I. Incidence of HL-A antibodies and possible association with congenital anomalies.
    Terasaki PI; Mickey MR; Yamazaki JN; Vredevoe D
    Transplantation; 1970 Jun; 9(6):538-43. PubMed ID: 5447558
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetes teratogenicity is accompanied by alterations in macrophages and T cell subpopulations in the uterus and lymphoid organs.
    Savion S; Gidon-Dabush S; Fein A; Torchinsky A; Toder V
    Int Immunopharmacol; 2004 Oct; 4(10-11):1319-27. PubMed ID: 15313430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunofluorescent and cytotoxic study of teratogenic immune serums].
    Eyquem A; Gutman G; Bisson JP; Mercier-Parot L; David G; Tuchmann-Duplessis H
    Ann Inst Pasteur (Paris); 1968 Nov; 115(5):841-54. PubMed ID: 4881808
    [No Abstract]   [Full Text] [Related]  

  • 14. [The reaction of antistreptococcal serum with different guinea pig tissues as demonstrated by the fluorescent antibody technic].
    Danilova TA
    Biull Eksp Biol Med; 1967 May; 63(5):70-2. PubMed ID: 4914784
    [No Abstract]   [Full Text] [Related]  

  • 15. [The pathogenic effect of nephrocytotoxic serum on the embryonic development of white rats].
    Mikhaĭlov VM
    Biull Eksp Biol Med; 1967 Jun; 63(6):97-100. PubMed ID: 5622623
    [No Abstract]   [Full Text] [Related]  

  • 16. THE PRODUCTION OF CONGENITAL MALFORMATIONS USING TISSUE ANTISERA. II. THE SPECTRUM AND INCIDENCE OF MALFORMATIONS FOLLOWING THE ADMINISTRATION OF KIDNEY ANTISERUM TO PREGNANT RATS.
    BRENT RL
    Am J Anat; 1964 Nov; 115():525-41. PubMed ID: 14211395
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the organ specificity of heterologous antiserums against eye tissue].
    Sonntag HG; Kraus E; Müller-Ruchholtz W
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1970; 70():32-9. PubMed ID: 5537491
    [No Abstract]   [Full Text] [Related]  

  • 18. The production of congenital defects in rats using antisera.
    Barrow MV; Taylor WJ
    J Exp Zool; 1971 Jan; 176(1):41-59. PubMed ID: 5101843
    [No Abstract]   [Full Text] [Related]  

  • 19. The production of congenital malformations using tissue antisera. IV. Evaluation of the mechanism of teratogenesis by varying the route and time of administration of anti-rat-kidney antiserum.
    Brent RL
    Am J Anat; 1966 Nov; 119(3):555-62. PubMed ID: 5972736
    [No Abstract]   [Full Text] [Related]  

  • 20. The production of congenital malformations using tissue antisera. V. Fluorescent localization of teratogenic antisera in the maternal and fetal tissue of the rat.
    Slotnick V; Brent RL
    J Immunol; 1966 Apr; 96(4):606-10. PubMed ID: 5327679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.